Clinical trial
Changes in Prostate Specific Antigen Levels During Synergo Therapy-Intravesical…
NCT00491296 · HaEmek Medical Center, Israel, Other · Unknown status
Key facts
| NCT number | NCT00491296 |
|---|---|
| Title | Changes in Prostate Specific Antigen Levels During Synergo Therapy-Intravesical Chemotherapy Instillations Combined With Hyperthermia |
| Lead sponsor | HaEmek Medical Center, Israel, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Bladder Cancer |
| Intervention type | Device |
| Interventions | SYNERGO, SYNERGO-intravesical chemotherapy instillation combined with hyperthermia |
| Start date | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Jun 26, 2007 |
| Last update posted | Nov 7, 2008 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: